Forward Industries sells OEM, cuts staff and raises capital as core design falters

Forward Industries, Inc. (NASDAQ: FORD) - Quick read

Straight to the point: the company is shrinking its legacy distribution businesses, sold its OEM segment for a one‑time gain, cut staff, raised emergency capital via preferred stock and an equity line, but operating results from its remaining design business have weakened materially and liquidity remains a key risk.

Key facts & statistics (as reported)
* Revenues - three months ended June 30, 2025: $2,494,769; nine months ended June 30, 2025: $10,242,151.
* Cost of sales - Q: $3,115,727; 9M: $9,908,850.
* Gross profit/(loss) - Q: $(620,958) (gross loss); 9M: $333,301.
* Operating loss - Q: $(2,559,781); 9M: $(5,279,571).
* Loss from continuing operations - Q: $(2,404,353); 9M: $(5,124,337).
* Income from discontinued operations - Q: $1,554,331; 9M: $2,114,639 (includes gain on sale of OEM: $1,405,972).
* Net loss attributable to common shareholders - Q: $(860,300); 9M: $(3,019,976).
* Basic loss per share - continuing ops Q: $(2.17); discontinued ops Q: $1.40; basic loss per share Q: $(0.77).
* Cash (balance sheet date June 30, 2025): $1,263,162; management reports cash ≈ $5,600,000 at Aug 12, 2025 (post‑period financing).
* Working capital (June 30, 2025): $1,211,000; accumulated deficit: $(22,646,838).
* Total assets: $8,294,323; total liabilities: $4,943,358; shareholders' equity: $3,350,965.
* Related‑party note payable balance to Forward China: $600,000; due to Forward China current: $450,000 (June 30, 2025).
* Preferred equity issued: Series A‑1 stated value (liquidation preference) $4,925,000; Series B issued May 2025 (proceeds $1,000,000).
* Warrant liability (June 30, 2025): $402,888 (change in fair value gain of $160,223 recognized in period).
* Accounts receivable, net: $1,193,494; contract assets: $724,905.
* Customer concentration: two customers = 32.4% of consolidated net revenues (three months ended June 30, 2025).

What's happening inside the company
* Strategic shift: the retail distribution business was exited (July 2023) and the OEM distribution segment was sold in May 2025. Those lines are now presented as discontinued operations.
* Operations: the remaining business is the design segment (IPS and Kablooe). That segment lost its largest customer (insulin patch pump program) in Dec 2024 and has had weak utilization since; goodwill was impaired in Dec 2024 but no further impairment at June 30, 2025.
* Cost actions: management implemented workforce reductions (Jan and June 2025) and continues cost‑containment measures.
* Financing & governance: converted supplier payables to preferred stock to cure Nasdaq equity deficiency; issued Series B preferred stock (May 2025); established a $35M equity line of credit (ELOC) and has sold shares under it; sold ~263k shares in a registered direct offering after period end and received ~$2.23M; raised ~$2.432M via the ELOC (July 1-Aug 12, 2025).
* Management change & related‑party unwind: former CEO and Chairman (owner of Forward China) resigned May 16, 2025; related‑party sourcing agreement with Forward China terminated in connection with the OEM sale.

Income statement - positives
* Discontinued operations produced a significant one‑time benefit: income from discontinued ops of $1,554,331 (Q) and $2,114,639 (9M), including a gain on sale of the OEM segment of $1,405,972-this materially offsets ongoing operating losses in the period.
* Company took prompt cost actions (two workforce reductions) to reduce cash burn and preserve runway.
* Management secured fresh capital post‑period: Series B ($1.0M), ELOC liquidity and a registered direct offering (~$2.23M) - cash reported ~$5.6M on Aug 12, 2025, improving near‑term liquidity.

Income statement - negatives
* Revenue collapse: Q revenues down ~50.5% YoY (from $5,036,232 to $2,494,769); 9M down ~32.8% YoY - the loss of a single large design customer drove most of this decline.
* Gross margin deterioration: Q gross margin swung to a loss (gross loss $(620,958)); 9M gross margin compressed to 3.3% - utilization and mix issues in the design business.
* Large ongoing operating costs: G&A remains high (Q G&A $1,799,140) despite cuts, producing deep operating losses (Q operating loss $(2,559,781)).
* Dependence on a few customers: two/three customers represent a large share (32.4% / 42.5% of revenues in interim periods) - concentration risk persists.
* Going concern and balance sheet strain: accumulated deficit $(22.6M), working capital low ($1.21M), management flagged substantial doubt about continuing as a going concern for 12 months from issuance absent further financing.
* Related‑party complexity and contingent payments: outstanding obligations to Forward China (note $600k; post‑sale scheduled payments of $150k in July-Sept 2025) and past conversions of payables to preferred stock create structural dilution and governance complexity.
* Dilution & potential shareholder impact: preferred stock with stated liquidation preferences and convertible features plus a warrant liability and extensive potential anti‑dilutive instruments (1,234,000 potentially dilutive shares excluded from EPS calculations) may materially affect common shareholders.

Bottom line / Watch items
* The OEM sale and discontinued‑ops gain bought time and raised cash, but the core design business is under pressure after losing a large client; margins and utilization must recover to restore sustainable profitability.
* Near‑term liquidity has improved through May-Aug 2025 financings, but the company still faces concentrated revenue risk, related‑party legacy obligations, and shareholder dilution from preferred conversions, ELOC issuances and outstanding warrants.
* Monitor upcoming cash payments to Forward China, usage of the ELOC (pricing and dilution), customer wins or losses in the design segment, and any further G&A reductions or restructurings.

If you want, I can prepare a one‑page tracker highlighting cash runway scenarios under different revenue and financing assumptions, or extract the SEC table lines into a spreadsheet.